Individualising care for patients with chronic hepatitis C: predicting side effects and treatment response using genomic and proteomic approaches.

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1017139

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Patients undergoing treatment for hepatitis C must endure a treatment characterized by unpredictable treatment side effects and uncertainty about the likelihood of cure. This project will investigate genetic predictors of treatment related side-effects and protein markers to predict treatment response. Better definition of the risks and benefits of therapy, may facilitate patients and clinicians to make more informed decisions about treatment, thus individualising treatment and potentially improving the safety and efficacy of therapy.

Funded Activity Details

Start Date: 01-01-2011

End Date: 01-01-2012

Funding Scheme: Postgraduate Scholarships

Funding Amount: $55,575.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Gastroenterology and Hepatology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

clinical research | complications | genomics | hepatitis C infection | pharmacogenomics | prognosis | proteomics | translational research | treatment outcomes

Related Links